|
Re: So I was able to finally set up a one on one meeting with...
|
5
|
Resverlogix Corp.
|
Mar 14, 2022 11:19PM
|
|
INTERESTING BIG PHARMA ON HUNT?
|
5
|
Resverlogix Corp.
|
Nov 09, 2022 08:15PM
|
|
Re: IR
|
4
|
Resverlogix Corp.
|
Jan 18, 2023 08:45AM
|
|
Re: Providence Therapeutics
|
4
|
Resverlogix Corp.
|
Sep 14, 2021 12:41PM
|
|
Re: trying to making sense
|
4
|
Resverlogix Corp.
|
Mar 09, 2022 10:41PM
|
|
Re: Is this sleeping beauty
|
4
|
Resverlogix Corp.
|
Jul 16, 2020 06:01PM
|
|
MERK
|
4
|
Resverlogix Corp.
|
Sep 30, 2021 08:25AM
|
|
Re: Cost of Dilution/Public Offering v Private Placement
|
4
|
Resverlogix Corp.
|
Oct 08, 2020 03:36PM
|
|
Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients
|
4
|
Resverlogix Corp.
|
Apr 06, 2022 01:22PM
|
|
Re: Empowerment for the whining peasants, aka RVX retail...but only if you want it!
|
4
|
Resverlogix Corp.
|
May 28, 2022 08:48PM
|
|
Re: I see them...
|
4
|
Resverlogix Corp.
|
May 27, 2019 01:03PM
|
|
Re: RVX Board Thoughts Mar 18 2022 – Wishful Thinking
|
4
|
Resverlogix Corp.
|
Mar 20, 2022 02:33PM
|
|
Re: The 3 inflection points: SSRA, Top-Line, Full Data
|
4
|
Resverlogix Corp.
|
Sep 10, 2018 09:46AM
|
|
BeardownAZ
|
3
|
Resverlogix Corp.
|
Jan 18, 2023 08:51AM
|
|
Re: One week later....
|
3
|
Resverlogix Corp.
|
May 21, 2021 10:57PM
|
|
Re: Presentation
|
3
|
Resverlogix Corp.
|
Sep 11, 2020 08:54PM
|
|
Re: My general impressions
|
3
|
Resverlogix Corp.
|
Nov 16, 2019 04:38PM
|
|
Re: Good news thoughts
|
3
|
Resverlogix Corp.
|
Jan 18, 2022 12:09PM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
3
|
Resverlogix Corp.
|
Jun 14, 2020 03:20PM
|
|
News Release From Ir
|
3
|
Resverlogix Corp.
|
Feb 08, 2018 07:34AM
|
